multiple myeloma
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
multiple myeloma
Jul 25, 2024, 14:07 |
Insight
Learn how Carl Ola Landgren is creating a risk profile to personalize myeloma care - HealthTree Foundation
HealthTree Foundation shared on X: "Learn how Dr. C. Ola Landgren and his colleagues at…
Jul 25, 2024, 00:36 |
Blog
Diana Romero: AI, exploiting bacteria, multiple myeloma and more in the new issue of Nature Reviews Clinical Oncology
Diana Romero, Chief Editor at Nature Research, shared on LinkedIn: "A new issue of Nature…
Jul 22, 2024, 14:33 |
Career
Sharon Castellino has been appointed to the board of directors of The Leukemia and Lymphoma Society - Winship Cancer Institute
Winship Cancer Institute of Emory University shared a post on LinkedIn: "Winship pediatric hematologist Sharon…
Jul 22, 2024, 10:55 |
Blog
CPOEM Support Group webinar for patients with Multiple Myeloma
CPOEM Foundation shared on LinkedIn: "Creative Portal for Oncology Education and More (CPOEM Foundation) kick starts…
Jul 18, 2024, 15:39 |
Insight
Myeloma Paper of the Day, July 18th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Population-based study of 8672 myeloma…
Jul 16, 2024, 23:58 |
Blog
Jim Omel: 90 years personal experience dealing with multiple myeloma
Jim Omel, Patient Advocate, shared a post on X: ''These three had about 90 years…
Jul 16, 2024, 10:29 |
Blog
Jack Aiello was a shining example of a patient-advocate: passionate and selfless
Andrew Schorr, Co-Founder (retired) of Patient Power, shared on LinkedIn: "The loss of a friend…
Jul 16, 2024, 05:36 |
Opinion
Lingaraj Nayak: Post-transplant maintenance in Myeloma
Lingaraj Nayak, Assistant Professor at Tata Memorial Hospital, shared on X: "Post-transplant maintenance in Myeloma…
Jul 15, 2024, 02:35 |
Insight
The latest IACH Post-Congress Webinars
International Academy for Clinical Hematology (IACH) Shared on X: “Our latest IACH Post-Congress Webinars: Multiple…
Jul 14, 2024, 02:56 |
Drugs
Belamaf-based triplet regimens are effective in patients with R/R multiple myeloma - ASCO
ASCO shared on X: "The DREAMM-7 and DREAMM-8 studies established the effectiveness of belamaf-based triplet…
Jul 11, 2024, 14:47 |
Insight
Flow cytometry to predict when to offer boosters to patients with multiple myeloma
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Bruno Paiva, Director Flow…
Jul 10, 2024, 12:35 |
Opinion
Manni Mohyuddin reflects on the analysis of SLiM MM versus traditional CRAB MM
Manni Mohyuddin shared on X: “Finally an analysis of SLiM MM versus traditional CRAB MM.…
Jul 9, 2024, 14:42 |
Drugs
Vincent Rajkumar: FDA approval doesn’t necessarily mean standard of care
Vincent Rajkumar shared on X: "FDA approval doesn’t necessarily mean standard of care. For example,…
Jul 9, 2024, 06:35 |
Blog
Rahul Banerjee: Nice analysis of Australia/New Zealand multiple myeloma with emphasis on CRAB vs SLiM
Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X: “Now in The…
Jul 8, 2024, 19:42 |
Insight
Vincent Rajkumar: 2024 Update on multiple myeloma
Vincent Rajkumar shared on X: “2024 update on multiple myeloma is available open access! Latest ASCO24…
Jul 8, 2024, 17:31 |
Insight
Kai Rejeski: Underestimated aspect of CAR T-cell therapy: non-relapse mortality
Kai Rejeski, Visiting investigator at Memorial Sloan Kettering Cancer Center, shared on X: “Hot off…
Jul 7, 2024, 18:19 |
Insight
Shahrin Ahmed: Efficacy of CARVYKTI in multiple myeloma
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared on X: "The Phase III…
Jul 7, 2024, 17:38 |
Blog
Some myeloma updates by Manni Mohyuddin
Manni Mohyuddin shared on X: “Thanks again to Medscape for the opportunity to write about…
Jul 7, 2024, 14:46 |
Opinion
Rahul Banerjee: Fascinating 3-way randomized trial of neuromuscular training
Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X: “This is…
Jul 7, 2024, 10:05 |
Insight
Murali Janakiram: Targeting cancer stem cells in multiple myeloma
Murali Janakiram, Associate Professor in the Department of Hematology and Hematopoietic Cell Transplantation at City…
Jul 4, 2024, 03:09 |
Blog
C. Ola Landgren: Highlights in Multiple Myeloma From ASCO and EHA 2024
C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader…
Jul 4, 2024, 01:10 |
Blog
Matthew Cortese: Great talk by Jens Hillengass on frontline Multiple Myeloma treatment at the Upstate New York Cancer Symposium
Matthew Cortese, Associate Professor at Roswell Park, shared on X: "Great talk by our Myeloma…
Jul 3, 2024, 02:35 |
Insight
Rahul Banerjee: Fascinating small Ph2 trial on relapsed or refractory multiple myeloma
Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X: “Absolutely abscopal…
Jul 2, 2024, 11:41 |
Insight
Myeloma Paper of the Day, July 2nd, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Leukocyte Ig-like receptor B family…
Jun 30, 2024, 12:27 |
Insight
Myeloma Paper of the Day, June 30th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Comprehensive multiomics analysis identifies highly…
Jun 30, 2024, 07:03 |
Blog
Rebecca L. Zon recieves Physician-Scientist Training Award from the Damon Runyon Cancer Research Foundation - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “Congratulations to Dana-Farber’s Rebecca L. Zon, MD…
Jun 26, 2024, 14:40 |
Blog
Shahrin Ahmed: Providing solutions for one of the most challenging cancers
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared on X: . “Multiple…
Jun 26, 2024, 03:52 |
Opinion
Alexandros Alexandropoulos: Some thoughts on Multiple Melanoma clinical trials practice and restrictions
Alexandros Alexandropoulos, Hematologist at Laiko General Hospital, shared a post on X: "Some thoughts on Multiple…
Jun 24, 2024, 12:43 |
Insight
Myeloma Paper of the Day, June 24th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: CREB1 promotes expression of immune…
Jun 24, 2024, 01:01 |
Blog
Thierry Facon discusses the groundbreaking IMRO study - Media Medic
Media Medic posted on LinkedIn: " Exciting Highlights from the European Hematology Association (EHA) Conference! We're…
Jun 23, 2024, 13:10 |
Insight
Myeloma Paper of the Day, June 23rd, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: ARID1A, a member of SWI/SNF…
Jun 21, 2024, 08:50 |
Blog
Rahul Banerjee: All I care about in myeloma is VGPR report
Rahul Banerjee, Assistant Professor at UW Medicine, shared Rafael Fonseca's post on X, adding: …
Jun 21, 2024, 05:54 |
Blog
Gurbakhash Kaur: Love the level of engagement in the Multiple Myeloma community
Gurbakhash Kaur, Multiple Myeloma Specialist at UTSW Harold C. Simmons Comprehensive Cancer Center, shared on…
Jun 21, 2024, 02:21 |
Insight
Ross Firestone: Healthcare utilization in CAR T and bispecifics patients with Multiple Myeloma
Ross Firestone, Hematology/Oncology Fellow at Memorial Sloan Kettering Cancer Center, shared on X: “Excited to…
Jun 19, 2024, 15:42 |
Blog
Gerardo Rodríguez-Lobato: Exciting news CART and Myeloma research by Oriol Cardús
Gerardo Rodríguez-Lobato, Hematologist at Hospital Clínic of Barcelona, shared a post on X: "Exciting news CART…
Jun 18, 2024, 16:17 |
Insight
Myeloma Paper of the Day, June 18th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Myeloma patients with financial toxicity…
Jun 18, 2024, 15:42 |
Blog
Hamza Hashmi: Great kick-off to Best of ASCO updates with Binay Shah
Hamza Hashmi, Myeloma and Cellular Therapy Physician at Memorial Sloan Kettering Cancer, shared on X:…
Jun 18, 2024, 15:33 |
Societies
Natalia Schutz: Thanks EHA and the IMWG for the opportunity to moderate one of the oral sessions
Natalia Schutz, Hematologist at the Italian Hospital of Buenos Aires, shared on X: "Thanks EHA…
Jun 15, 2024, 13:48 |
Insight
Myeloma Paper of the Day, June 15th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Natural killer cells with adhesion…
Jun 15, 2024, 07:46 |
Insight
‘Myeloma Made Simple’ series by the International Myeloma Foundation
International Myeloma Foundation shared a post on X: “‘Myeloma Made Simple’ is a popular video…
Jun 14, 2024, 18:06 |
Insight
Humberto Martinez-Cordero: Our most recent publication on multiple myeloma in Latin America
Humberto Martinez-Cordero, Hematologist at National Cancer Institute - ESE, shared a post on X: "It…
Jun 13, 2024, 15:24 |
Insight
Myeloma Paper of the Day, June 13th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Low circulating tumor cell levels (0.02%…
Jun 13, 2024, 07:15 |
Blog
International Myeloma Foundation - The greatest minds in myeloma together each year at the IMFIMWG Summit
International Myeloma Foundation shared a post on X: "HAPPENING NOW: The IMF brings together 100 of…
Jun 13, 2024, 07:12 |
Blog
Vincent Rajkumar: 15th Annual International Myeloma Working Group summit opens in Madrid
Vincent Rajkumar shared a post on X: "15th Annual International Myeloma Working Group summit opens in…
Jun 13, 2024, 06:08 |
Blog
Rahul Banerjee: So honored to have gotten Shaji Kumar’s wisdom on so many multiple myeloma questions
Rahul Banerjee, Assistant Professor at the Fred Hutchinson Cancer Center, shared on X: "So honored to…
Jun 12, 2024, 15:07 |
Insight
Myeloma Paper of the Day, June 12th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Pre-clinical study finds acquired resistance…
Jun 11, 2024, 14:59 |
Insight
Timos Papagatsias: EHA24 is expected to be one of the most exciting EHA conferences to-date!
Timos Papagatsias, CEO of LucidQuest shared a post on LinkedIn: “EHA24 is fast approaching and…
Jun 11, 2024, 12:59 |
Insight
Myeloma Paper of the Day, June 11th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Phase II trial of ixazomib/daratumumab/dexamethasone…
Jun 11, 2024, 11:27 |
Blog
Rahul Banerjee: Excellent multiple myeloma work in Blood Cancer Journal
Rahul Banerjee, Assistant Professor at the Fred Hutchinson Cancer Center, shared a post by Mattia D'Agostin,…
Jun 11, 2024, 10:23 |
Blog
Vincent Rajkumar: The priorities for what’s next in myeloma research has changed
Alexandros Alexandropoulos, Hematologist at Laiko General Hospital, shared a post by Vincent Rajkumar, on X: "Some…
Jun 11, 2024, 02:30 |
Blog
Vincent Rajkumar: With recent advances, the priorities for what is next in myeloma research has changed
Vincent Rajkumar shared a post on X: “With recent advances, the priorities for what is next…
Jun 9, 2024, 10:29 |
Insight
Myeloma Paper of the Day, June 9th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Progression of MGUS to multiple…
Jun 7, 2024, 09:03 |
Insight
Researchers at MSK are making strides against cancer every day - Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center shared a post on X: “Researchers at MSK are making…
Jun 7, 2024, 08:19 |
Societies
Monique Minnema: Proud to be asked by the ASCO to have a discussion at ASCO24
Monique Minnema, Medical Doctor at University Medical Center Utrecht, recently shared on LinkedIn: "Proud to…
Jun 5, 2024, 14:51 |
Blog
Diko Kazandjian: IsaVRD more is better
Dickran (Diko) Kazandjian, Professor of Medicine at the Sylvester Comprehensive Cancer Center and Board Member…
Jun 4, 2024, 16:31 |
Societies
Just presented at ASCO24: IMROZ results by C. Ola Landgren - ASCO
ASCO shared a post on X: “Just presented at American Society of Clinical Oncology 2024…
Jun 4, 2024, 14:44 |
Insight
Myeloma Paper of the Day, June 4th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Phase III BENEFIT trial shows…
Jun 3, 2024, 22:00 |
Insight
Myeloma Paper of the Day, June 3rd, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Comparison of infectious complications with…
Jun 2, 2024, 15:31 |
Insight
Myeloma Paper of the Day, June 2nd, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: DREAMM-7 study shows belantamab/bortezomib/dexamethasone superior…
Jun 1, 2024, 13:17 |
Blog
Tom Snow: Sanofi will be presenting new data in multiple myeloma at ASCO24
Tom Snow, General Manager at Sanofi, shared a post on LinkedIn: "I'm thrilled to be at…
Jun 1, 2024, 12:03 |
Insight
Myeloma Paper of the Day, June 1st, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: MALT1 inhibition suppresses BCMA-induced NF-κB…
Jun 1, 2024, 02:42 |
Insight
Myeloma Paper of the Day, May 31st, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Phase II trial of Dara-KRd…
May 30, 2024, 13:13 |
Insight
Myeloma Paper of the Day, May 30th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: A geriatric assessment-guided multidisciplinary clinic…
May 29, 2024, 12:04 |
Blog
Tom Snow: The FDA accepted for Priority Review Sanofi’s application for investigational therapy in multiple myeloma
Tom Snow, General Manager at US Oncology, Sanofi, shared a post on LinkedIn: “Today, the…
May 29, 2024, 09:46 |
Blog
Top 7 ASCO24 abstracts to watch for multiple myeloma by Samer Al Hadidi
Samer Al Hadidi, Assistant professor at UAMS Myeloma Center, shared a post on X: "My top…
May 28, 2024, 14:06 |
Insight
Myeloma Paper of the Day, May 28th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Retrospective Memorial Sloan Kettering study suggests…
May 27, 2024, 08:13 |
Insight
Rafael Fonseca: Multiple myeloma (MM) – subclonal, and not?
Rafael Fonseca, Chief Innovation Officer at Mayo Clinic in Arizona, recently shared a post on…
May 26, 2024, 14:20 |
Blog
C. Ola Landgren on Quadruple Therapies and the Future of Multiple Myeloma Treatment
Sylvester researcher C. Ola Landgren will present an overview of new studies and the state…
May 24, 2024, 13:11 |
Blog
Kelley Wood: We observed significant improvements in Quality of Life across 12 different cancer types
Kelley Wood, Research Director at ReVital Cancer Rehab, made the following post on LinkedIn: “NEW PUB…
May 24, 2024, 03:21 |
Insight
Myeloma Paper of the Day, May 23rd, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Proposal for harmonizing reporting of…
May 24, 2024, 01:21 |
Insight
Recent FDA Committee Vote Could Speed Multiple Myeloma Drug Approval
Sylvester-led analysis on minimal residual disease as clinical endpoint guided committee decision A U.S. Food…
May 22, 2024, 13:03 |
Insight
Myeloma Paper of the Day, May 22nd, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Nice review of the challenges…
May 22, 2024, 12:03 |
Insight
Nico Gagelmann: Spotter in hematology. A short thread with some snapshots and diagnosis
Nico Gagelmann, Chair of CAR-T for Plasma Cell Disorder Committee and Chair Trainee Committee at…
May 21, 2024, 15:55 |
Insight
Myeloma Paper of the Day, May 21st, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Clinical trial of academic BCMA…
May 21, 2024, 15:48 |
Blog
Cancer Network - A panel of experts on multiple myeloma discuss the rationale for CAR T-cell therapy
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Cancer Network, on X: "So much fun…
May 21, 2024, 15:16 |
Blog
A panel of experts on multiple myeloma discuss the rationale for CAR T-cell therapy - Cancer Network
Cancer Network shared a post on X: "A panel of experts on multiple myeloma discuss…
May 20, 2024, 05:06 |
Insight
Myeloma Paper of the Day, May 19th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Pilot study of a physical activity…
May 18, 2024, 15:37 |
Insight
Myeloma Paper of the Day, May 18th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Myeloma patients with long remission post-ASCT…
May 17, 2024, 13:11 |
Insight
Yelak Biru: Kite and Arcellx have announced plans to commence a Phase III clinical trial for myeloma
Yelak Biru, President and CEO of the International Myeloma Foundation, shared on X: . "We…
May 15, 2024, 14:51 |
Blog
Rahul Gosain: HemeSeries with Samer Al Hadidi for Relapsed/Refractory Multiple Myeloma
Rahul Gosain, Director of Regional Infusion Services at Wilmot Cancer Institute, shared on LinkedIn: "HemeSeries: with Samer…
May 14, 2024, 08:19 |
Insight
Myeloma Paper of the Day, May 13th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
May 13, 2024, 13:34 |
Blog
Gurbakhash Kaur: Debating early intervention in smoldering myeloma
Gurbakhash Kaur, Multiple Myeloma Specialist at UTSW Harold C. Simmons Comprehensive Cancer Center, shared on…
May 13, 2024, 08:24 |
Blog
Monica Bertagnolli: AI Tool Has Promise for Matching Cancer Drugs to Patients
Monica Bertagnolli shared a post on LinkedIn: ''AI Tool Using Single-Cell Data Has Promise for Optimally…
May 12, 2024, 13:01 |
Insight
Myeloma Paper of the Day, May 12th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
May 11, 2024, 13:14 |
Insight
Myeloma Paper of the Day, May 11th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
May 10, 2024, 01:01 |
Insight
Myeloma Paper of the Day, May 9th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
May 8, 2024, 13:47 |
Insight
Myeloma Paper of the Day, May 8th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
May 8, 2024, 02:28 |
Insight
Myeloma Paper of the Day, May 7th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X/Twitter: "Myeloma…
May 7, 2024, 15:56 |
Blog
Sylvester Comprehensive Cancer Center - Firefighter Cancer Initiative and David Perez' story
Sylvester Comprehensive Cancer Center shares a story of a firefighter diagnosed with multiple myeloma discussing…
May 5, 2024, 11:03 |
Insight
Madelon de Jong: My final PhD paper is out in Nature Immunology
Madelon de Jong, a Researcher at the Kennedy Institute of Rheumatology, shared a post on…
May 5, 2024, 09:11 |
Insight
Myeloma Paper of the Day, May 5th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
May 4, 2024, 15:56 |
Insight
Myeloma Paper of the Day, May 4th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
May 1, 2024, 07:24 |
Insight
Myeloma Paper of the Day, April 30th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
Apr 30, 2024, 07:31 |
Insight
Top 5 posts of the week by Cancer Network
Cancer Network shared on their X/Twitter page: "View our top 5 posts of the week:…
Apr 29, 2024, 23:03 |
Insight
Manni Mohyuddin: Aaron Goodman and I draw attention to over treatment of multiple myeloma and its precursor states
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute, University of Utah, recently posted on…
Apr 29, 2024, 00:23 |
Blog
David Lennard: Reading about a cancer journey isn’t to everyone’s taste, but it should be
David Lennard, Multiple Myeloma Warrior and Photographer, shared a post on X/Twitter by Tutti Frutti…
Apr 28, 2024, 15:27 |
Insight
Ross Firestone: Happy to see my first research paper of fellowship is officially in press
Ross Firestone, Hematology/Oncology Fellow at Memorial Sloan Kettering Cancer Center, shared on their X/Twitter: ''Happy…
Apr 26, 2024, 14:15 |
Drugs
Carl Ola Landgren: With Minimal Residual Disease (MRD) as an early endpoint for accelerated approval of new multiple myeloma drugs, patients access to new therapies will be much quicker
Apr 25, 2024, 20:28 |
Insight
Myeloma Paper of the Day, April 25th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
Apr 24, 2024, 13:27 |
Insight
Myeloma Paper of the Day, April 24th, suggested by Robert Orlowski
Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X: "Myeloma…
1
2
All:
149
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube